Tag: Trump administration
Trump ramps up denaturalization push with 2026 quota targeting naturalized citizens
Internal USCIS guidance reportedly calls for 100 to 200 denaturalization referrals per month, signaling a sharp escalation that experts say collides with legal limits and historical practice.
Senate approves record Pentagon budget as Democrats help advance Trump’s defense...
Bipartisan vote sends $900 billion military bill to Trump’s desk amid war powers concerns and domestic cuts.
FBI is making an enemies list—and most corporate media didn’t even...
The counter-revolution will not be televised.
Supreme Court takes up Trump attack on birthright citizenship
A clash over the 14th amendment heads to the justices with consequences for millions of families.
Trump administration threatens to withhold SNAP funds from democratic-led states
A new confrontation between the White House and blue states raises concerns about the political use of food assistance programs.
Trump DOJ backs Bayer in Supreme Court fight over Roundup cancer...
A move by the administration aligns federal power with pesticide manufacturers as thousands of cancer patients fight for their day in court.
White House defense of Trump boat killings raises alarm over war...
After confirming a second strike that killed survivors of a September boat bombing, the White House insists President Trump can target anyone labeled a “narco-terrorist” while legal experts and lawmakers warn the actions resemble murder, not self defense.
Hegseth order to “kill everybody” triggers war crimes alarms
New reporting on a lethal September boat strike intensifies scrutiny of Trump’s regional military campaign.
A $1.6 billion fraud case that affected thousands ended in a...
Trump’s commutation of GPB Capital founder raises concerns about white-collar accountability
Make drug price cuts visible: Biden-era law delivers savings for 15...
A new round of Medicare drug price negotiations shows the impact of the Inflation Reduction Act while exposing an ongoing political fight over who deserves credit for lowering drug costs.











